Effect of the warming and tonifying kidney- yang recipe on monoamine neurotransmitters and pathological morphology of hippocampus tissue in depression model rats

1.Introduction

Depression is a type of mental disorder characterized by significant and persistent depression, decreased mobility, and sluggish thinking and cognition. As is reported by the World Health Organization, there are over 300 million persons around the world living with depression. Many studies have shown that some traditional Chinese medicine (TCM) remedies offer an antidepressant effect [1, 2, 3] and fewer side effects than Western antidepressants [4]. According to TCM theory, depression belongs to “Yu Zheng.” In addition to liver-qi stagnation, kidney-yang deficiency is an important pathogenesis of depression [5]. Kidney-yang can promote the operation of yang-qi, and kidney-yang deficiency is characterized by a low mood, lack of spirit, apathy, obtuse behavior, and decreased vitality. The warming and tonifying kidney-yang recipe (WTKYR) was developed to warm and tonify kidney-yang and was recorded in the “Golden Chamber.” Clinical applications have found that the abnormal emotional state of depression patients may be significantly improved by WTKYR. Previous animal experiments have also shown that WTKYR can diminish abnormal behavior in depression model rats and upregulate the AC – cAMP – PKA – CREB – BDNP signaling pathway [6].

Monoamine neurotransmitters such as 5-HT, NE, and DA transmit information between neurons or between nerves and effector cells, acting a major role in the regulation of emotion [7]. Dysfunction of the monoamine neurotransmitters’ metabolic system is the key to depression. Zhang et al. [8] found on autopsy that the abnormal neurotransmitter was mainly expressed as the decrease of 5-HT synthesis in the brain. Reduced NE concentration in the hypothalamus of depressed patients suggests that depression is associated with low central NE function [9]. DA dysfunction is also related to the pathophysiology of depression, [10] and Malhi and Berk [11] found that it is closely associated with psychomotor disorders. DA dysfunction can lead to damaged plasticity in hippocampus-frontal cortex synapses, resulting in cognitive dysfunction [12].

It is reported that depression is closely associated with changes in brain structure that regulate mood and cognitive function [13]. The hippocampus serves an important role in the brain by participating in the processes of memory and emotion, autonomic activity, and endocrine integration. In recent years, the hypothesis of adult hippocampal neurogenesis has dominated the study of depression [14, 15]. Numerous experiments have demonstrated that the hippocampus of depression patients is significantly reduced [16, 17].

2.Materials and methods

2.7Statistical analysis

Statistical Product and Service Solutions (SPSS) 20.0 software was performed to analyze the data. The data of body weight and SPT were analyzed by the repeated measures analysis of variance. The data of the open field test and the concentration of monoamine neurotransmitters were analyzed by single-factor analysis of variance. P values were accepted as significant at p< 0.05.

Figure 1.

Body weight (A) and SPT (B) results of all groups at baseline (the last day of modeling) and at the end of each treatment week. As shown in Fig. 1A, all groups that received CUMS modeling had lower body weights than the control group. The rats in the fluoxetine group and WTKYR group gradually gained weight during the treatment, but there remained an obvious discrepancy with the control group by the end of the therapy. The SPT data indicated no difference among the four groups at baseline. With the progress of treatment, rats in the WTKYR group consumed more sucrose than the model group. In the last two weeks of treatment, rats in the WTKYR group displayed remarkable higher sucrose consumption than the control group. The symbol ‘*’ indicated that p-value is lower than 0.05 when compared with the control group, and the symbol ‘#’ expressed that p-value is lower than 0.05 when compared with the model group.

3.Results

3.1Rats’ body weight, SPT, and vitality of CUMS rats

The rats’ weight (Fig. 1A) and SPT (Fig. 1B) were checked after modeling and weekly therapy. The results suggested that the body weight of the WTKYR group increased and was remarkably different than the control group (p< 0.05). The SPT results displayed that the WTKYR group consumed more sucrose than the other groups at the last two weeks (p< 0.05). When compared with the control group, the open field test result showed that the crossing scores (Fig. 2A) and the rearing scores (Fig. 2B) of the WTKYR, fluoxetine and model group had significantly decreased after modeling (p< 0.05). After treatment, the fluoxetine and WTKYR groups displayed higher scores than the model group (p< 0.05).

Figure 2.

Crossing scores (A) and rearing scores (B) in open field tests of the four groups. The results displayed that the crossing scores of rats in the model, WTKYR, and fluoxetine groups were lower than the control group at baseline. A significant increase was displayed in the WTKYR group when compared with the model and fluoxetine groups at the second week of treatment. It was noted that both the WTKYR and fluoxetine group rats recorded higher crossing scores in the last week, and then no significant difference was observed among the WTKYR, fluoxetine group and the control group. Figure 2B displayed the rearing scores of the model, WTKYR, and fluoxetine groups decreased after modeling. After two weeks of treatment, the rearing scores of the fluoxetine group and WTKYR group were increased compared with the model group, but still lower than the control group. And no significant difference among the WTKYR, fluoxetine, and control groups were found until the last week of treatment.

3.2The 5-HT, NE, and DA concentration of CUMS rats

Compared to the model group, the concentration of hippocampus 5-HT (Fig. 3A) in the WTKYR group was notably higher (p< 0.05), and no remarkable contrast was observed between the WTKYR and control groups. As shown in Fig. 3B and C, hippocampus NE and DA concentrations of the WTKYR group were found to be remarkably different from those of the control and model groups.

Figure 3.

Results of 5-HT (A), NE (B), and DA (C) of rats in all groups. As shown in Fig. 3A, the concentrations of hippocampus 5-HT in the fluoxetine group and the WTKYR group were remarkably higher compared with the model group, and there was no statistical difference when contrast the fluoxetine and WTKYR group with the control group. Hippocampus NE and DA content of the WTKYR group were higher than in the model group and lower than in the control group. The fluoxetine group showed a higher NE and DA concentration than the model group.

Figure 4.

Hippocampus histomorphology of the groups: control (A), model (B), WTKYR (C), and fluoxetine group (D). It was noted that hippocampus histomorphology of the control group was normal. Moderate pyramidal cell edema and infiltration of inflammatory cells were observed in the model group. There was lighter cell edema and inflammation in the rats’ hippocampus tissue of the fluoxetine and WTKYR groups. The black arrows in Fig. 4 point to the cell edema, and the red point to the inflammatory cell infiltration. Bar = 100 μm.

4.Discussion

In the study of the etiological factor of depression, the deficiency of monoamine neurotransmitters in the brain, for instance, NE, 5-HT, and DA, has been widely recognized [19]. According to the monoamine neurotransmitter theory, depression is caused by the insufficiency of the monoamine neurotransmitters NE and 5-HT in the brain. In 1965, Coppen [20] found that the lack of 5-HT in the central nervous system can cause depression, which was later confirmed by many scholars. Numerous studies have shown that DA may be involved in the pathogenesis of depression and that the therapeutic effect of drugs on depression may be achieved through enhancing the sensitivity of dopamine receptors [21]. During depression, the content and function of monoamine neurotransmitters may change. In the present study, hippocampus 5-HT, NE, and DA concentrations of the depression model rats were noticed to significantly decrease when compared with the control group, indicating that depression was related to the content of monoamine neurotransmitters. WKTYR may improve the content of 5-HT, NE, and DA of CUMS rats and ameliorate the depressive state of rats, suggesting that WKTYR may be effective in upregulating monoamine neurotransmitters. Anhedonia is one of the typical symptoms of depression, and it may be represented by a reduced preference for sucrose in SPT. In this study, increased consumption of sucrose was observed in the WTKYR group during the last two weeks, indicating that WTKYR may reverse the anhedonia of CUMS depression rats.

The cerebrum lesion is an important etiological factor of depression. Most depression patients have structural changes in the brain [22, 23] that might lead to depressive symptoms such as mental and emotional disorders [24]. As an important part of the brain that is closely related to memory and emotion, the hippocampus acts a considerable part in the pathogenesis of depression. The hippocampus of the depression model rats had changes in amino acid metabolism and impaired protein synthesis and degradation [25]. It has been reported that long-term stress can cause hippocampal neuronal degeneration and pyramidal cell edema in rats [26, 27]. This study found that the hippocampus was intact in the control group, with no pyramidal cell edema or inflammatory cell infiltration. Moderate pyramidal cell edema and infiltration of inflammatory cells were observed in the model group. Although pathological changes were observed in the WTKYR group, pyramidal cell edema and the infiltration of inflammatory cells were extenuated. This suggests that WKTYR may achieve therapeutic effects by mitigating pyramidal cell edema and infiltration of inflammatory cells into brain tissue.